Clinical Trial Update: Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Lag-3 blockade with gemcitabine for advanced pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Lag-3

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreatic Neoplasms | Phase 1 | Status: TERMINATED